ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in London, England

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Cancer
Carcinoma
Breast Cancer
Ovarian Cancer
Triple Negative Breast Cancer
Ovarian Epithelial Carcinoma
Colorectal Cancer

Endometrial Cancer trials near London, England, GBR:

Refining Adjuvant Treatment in Endometrial Cancer Based on Molecular Features (RAINBO)

The RAINBO umbrella program consists of four clinical trials investigating new adjuvant therapies in endometrial cancer patients. E ...

Enrolling
Endometrial Cancer
Radiation: Vaginal brachytherapy
Drug: Megestrol Acetate

Phase 2, Phase 3

Leiden University Medical Center (LUMC)

London, United Kingdom and 13 other locations

Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...

Enrolling
Endometrial Cancer
Drug: Paclitaxel
Drug: Nab-paclitaxel

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

London, London, City Of, United Kingdom and 242 other locations

study to evaluate the efficacy and safety of dostarlimab versus carboplatin-paclitaxel in patients with MMR deficient relapse or advanced endometrial...

Active, not recruiting
Endometrial Cancer
Drug: Carboplatin-Paclitaxel
Drug: Dostarlimab

Phase 3

ARCAGY/ GINECO GROUP

London, United Kingdom and 94 other locations

DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd + rilvegostomig (Arm A) and/or T-DXd+ pembrolizumab (Arm B) when com...

Enrolling
Endometrial Cancer
Drug: Carboplatin
Drug: Paclitaxel

Phase 3

AstraZeneca
AstraZeneca

London, United Kingdom and 237 other locations

participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....

Active, not recruiting
Neoplasms
Drug: Paclitaxel
Drug: Carboplatin

Phase 3

Tesaro
Tesaro

London, United Kingdom and 168 other locations

The goal of this clinical study is to find out how the study drug, sacituzumab govitecan (SG) works in participants with endometrial cancer...

Enrolling
Endometrial Cancer
Drug: Paclitaxel
Drug: Sacituzumab govitecan-hziy

Phase 3

Gilead Sciences
Gilead Sciences

London, United Kingdom and 170 other locations

The purpose of this study is to characterize the safety and tolerability of ALTA2618 in adults with AKT1 E17K-mutant advanced solid tumors....

Enrolling
Metastatic Cancer
Endometrial Cancer
Drug: ALTA2618

Phase 1

Alterome Therapeutics, Inc.

London, United Kingdom and 45 other locations

This research is designed to determine if experimental treatment with Antibody-drug conjugate, AZD5335, alone, or in combination with anti-cancer...

Enrolling
Endometrial Cancer
Ovarian Cancer
Drug: Bevacizumab
Drug: Carboplatin

Phase 1, Phase 2

AstraZeneca
AstraZeneca

London, United Kingdom and 58 other locations

durvalumab (MEDI4736) in patients with relapsed gynaecological cancers to assess the response in groups of patients selected based on their ...

Enrolling
Gynaecological Cancers
Drug: Durvalumab
Drug: Ceralasertib

Phase 2

Institute of Cancer Research, United Kingdom

London, United Kingdom and 8 other locations

This is a proof-of-concept study designed to investigate HER3-DXd monotherapy in locally advanced unresectable or metastatic solid tumors. T ...

Enrolling
Breast Cancer
Esophageal Cancer
Drug: HER3-DXd

Phase 2

Daiichi Sankyo
Daiichi Sankyo

London, United Kingdom and 74 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems